Trial Details

TERMINATED
Basic Information
Clinical ID c1787
Identifier NCT02596893
Trial Title Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: GED-0301|DRUG: Placebo
Participant Information
Sponsor Celgene
City Huntsville
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-12-08
Primary Completion Date 2018-01-05
Completion Date 2018-01-05